Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab
Anticancer Research · 2026
DOI: 10.21873/anticanres.18358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Masaki Omori und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan. Hauptthemen laut MEDLINE: Liver Neoplasms, alpha-Fetoproteins, Antibodies, Monoclonal, Humanized, Carcinoma, Hepatocellular.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine, Kobe, Japan; komasho8@med.kobe-u.ac.jp.
- Department of Internal Medicine, Division of Gastroenterology, Kobe University Graduate School of Medicine, Kobe, Japan.
- Department of Radiology, Kobe University Graduate School of Medicine, Kobe, Japan.
- Division of Oncology, Kobe Minimally invasive Cancer Center, Kobe, Japan.
- Division of Radiology, Kobe Minimally invasive Cancer Center, Kobe, Japan.
Zitieren
APA
Omori, M., Komatsu, S., Tada, T., Ishihara, N., Matsuura, T., Ueshima, E., Fujishima, Y., Ishida, J., Kido, M., Gon, H., Fukushima, K., Urade, T., Yanagimoto, H., Sofue, K., Kodama, Y., & Fukumoto, T. (2026). Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab. Anticancer Research. https://doi.org/10.21873/anticanres.18358
Vancouver
Omori M, Komatsu S, Tada T, Ishihara N, Matsuura T, Ueshima E, et al. Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab. Anticancer Research. 2026. doi:10.21873/anticanres.18358
BibTeX
@article{Omori2026,
author = {Omori, Masaki and Komatsu, Shohei and Tada, Toshifumi and Ishihara, Nobuaki and Matsuura, Takanori and Ueshima, Eisuke and Fujishima, Yoshimi and Ishida, Jun and Kido, Masahiro and Gon, Hidetoshi and Fukushima, Kenji and Urade, Takeshi and Yanagimoto, Hiroaki and Sofue, Keitaro and Kodama, Yuzo and Fukumoto, Takumi},
title = {Early LMR Dynamics and AFP Status in Advanced HCC Treated With Atezolizumab/Bevacizumab},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18358}
}
EUVIMED